HypertensionNCT07894068
IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients
A study testing IMB Model-Guided Health Education Intervention in people with Hypertension, run by Bahir Dar University at 8 sites in Ethiopia.
Trial summary
This study will evaluate the effectiveness of an Information-Motivation-Behavioral Skills (IMB) Model-guided health literacy intervention among adults with hypertension who are non-adherent to prescribed antihypertensive medication. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension
- What is being tested?
- IMB Model-Guided Health Education Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 230 participants
- Where
- 8 sitesEthiopia
- Study dates
- 25 Jun 2026to 25 May 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 18 years and above.
- Documented diagnosis of hypertension (BP ≥140/90)
- ≥6 months on antihypertensive medication (this duration ensures stabilization of treatment regimens and allows reliable assessment of persistent medication adherence behavior and blood pressure outcomes).
- Identified as having poor medication adherence
Who cannot join
- 1. Severe comorbidities that limit life expectancy or participation
Trial locations and contacts
8 sites in 1 country. Contact the study team or a site near you to ask about taking part.
8 sites in 1 country
Ethiopia8 sites, 8 recruiting
- Recruiting
Adet Primary Hospital
Ādēt
Mengistu Yayeherad Mr, Master, +251995597078, mengistu.yayehrad@gmail.com
- Recruiting
Adis Alem Primary Hospital
Ādīs ‘Alem
Miheret Alebel Mr., First Degree, +251928507199, miheretalebel234@gmail.com
- Recruiting
Adiss alem
Bahir Dar
Tena Fentaw Sr., First Degree, +251942319434, fentaw.tena@gmail.com
- Recruiting
Felehiwote
Bahir Dar
Zelalem Antenhe Mr., First Degree, +251918160306, zelalem.ante@gmail.com
- Recruiting
Tibebe Ghion
Bahir Dar
Hashem Alikader Mr., First Degree, +251918147192, Hashem.ali@gmail.com
- Recruiting
Durbete Primary Hospital
Gurbetē
Tayachew Melse Mr., Master, +251920248655, tayu.melse21@gmail.com
- Recruiting
Liben Hospita
Līben
Samuel Ayalew Mr., Master, +2510918769701, sami.ayalew@gmail.com
- Recruiting
Merawi Hospital
Mēch’a
Shegaw Tilahun Mr., Master, +251918329960, fentahunminaye278@gmail.com
About this study
Official title: Effectiveness of Information-Motivation-Behavioral Skills -Based Intervention on Medication Adherence and Blood Pressure Control in North Ethiopia: A Cluster Randomized Controlled Trial
This study will evaluate the effectiveness of an Information-Motivation-Behavioral Skills (IMB) Model-guided health literacy intervention among adults with hypertension who are non-adherent to prescribed antihypertensive medication. The study will use a cluster randomized controlled trial design in eight public hospitals in North Ethiopia. Four hospitals will be allocated to the intervention group and four to the usual-care control group.
The intervention will address information, motivation, and behavioral skills related to medication adherence and hypertension self-management. Participants in the intervention group will receive the IMB Model-guided health literacy intervention in addition to usual care, while participants in the control group will receive usual care.
Read more
The primary outcome is medication adherence. Blood pressure control and other specified hypertension self-management outcomes will be assessed as secondary outcomes. In addition, a qualitative component will explore the perceptions, experiences, and contextual barriers of medication non-adherent hypertensive patients regarding the information, motivation, and behavioral skills that influence their medication adherence and hypertension self-care behaviors.
The study will test the hypothesis that the IMB Model-guided health literacy intervention will improve medication adherence compared with usual care. The qualitative component will provide contextual information to help explain participants' experiences and the factors influencing medication-taking behavior and intervention implementation.
Read the detailed description
This study is a mixed-methods study incorporating a cluster randomized controlled trial and a qualitative component. The quantitative component will evaluate the effectiveness of an Information-Motivation-Behavioral Skills (IMB) Model-guided health literacy intervention on medication adherence among non-adherent adults with hypertension.
The quantitative component will be conducted in eight public hospitals in North Ethiopia. Four hospitals will be allocated to the intervention group and four hospitals to the usual-care control group. Eligible adults with hypertension who meet the study criteria for medication non-adherence will be enrolled and followed according to the study protocol.
The intervention is guided by the Information-Motivation-Behavioral Skills Model. The information component will provide understandable and culturally appropriate information about hypertension, antihypertensive medications, medication adherence, and hypertension self-management. The motivation component will address personal and social factors influencing medication-taking behavior and provide appropriate motivational support. The behavioral skills component will focus on practical skills for establishing medication-taking routines, using reminders, addressing barriers to adherence, managing medication-related difficulties, problem-solving, and developing appropriate hypertension self-management strategies.
Participants in intervention hospitals will receive the IMB Model-guided health literacy intervention in addition to usual care. Participants in control hospitals will receive usual care provided by the participating health facilities. The intervention will be delivered according to the study protocol and standardized intervention materials, with appropriate procedures for monitoring intervention fidelity.
The primary quantitative outcome is medication adherence. Medication adherence will be assessed using the instrument and outcome definition specified in the approved study protocol. Blood pressure control will be assessed as a secondary outcome using standardized blood pressure measurement procedures. Other secondary outcomes will include the additional outcomes specified in the study protocol.
The qualitative component will explore the perceptions, experiences, and contextual barriers of medication non-adherent hypertensive patients regarding the information, motivation, and behavioral skills that influence medication adherence and hypertension self-care behaviors. The qualitative component will examine participants' understanding and experiences related to hypertension and antihypertensive medications, their sources of information, personal and social motivation for medication-taking, behavioral skills related to medication adherence and hypertension self-management, and contextual barriers that may influence these factors. It will also explore participants' experiences and perspectives regarding the challenges they face in maintaining medication adherence and hypertension self-care behaviors.
Qualitative data will be collected from purposively selected medication non-adherent hypertensive patients according to the qualitative component of the study protocol. The interviews will provide an in-depth understanding of the factors influencing medication-taking and hypertension self-care behaviors from the participants' perspectives. Qualitative data will be analyzed using an appropriate analysis approach, with findings organized around the information, motivation, behavioral skills, and contextual factors identified in the qualitative objective.
Data collection for both components will follow standardized procedures. Quantitative data will be collected by trained data collectors, and appropriate measures will be taken to maintain data quality and participant confidentiality. Qualitative interviews will be conducted by appropriately trained researchers, documented, transcribed, and analyzed according to the study protocol. Findings from the qualitative component will be considered alongside the quantitative findings to provide contextual understanding of medication adherence and hypertension self-care behaviors among medication non-adherent hypertensive patients.
The primary quantitative hypothesis is that participants receiving the IMB Model-guided health literacy intervention will demonstrate improved medication adherence compared with participants receiving usual care. The qualitative component will complement the quantitative findings by providing contextual information about participants' perceptions, experiences, and barriers related to information, motivation, and behavioral skills that influence medication adherence and hypertension self-care behaviors.
- Conditions
- Hypertension
- Being tested
- IMB Model-Guided Health Education Intervention, Usual Care
- Keywords
- Antihypertensive medication, Ethiopia, Hypertension self-management, IMB model
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
IMB Model-Guided Health Education InterventionBehavioural
Participants allocated to the intervention arm will receive a structured, face-to-face health literacy intervention in addition to usual hypertension care. The intervention will be guided by the IMB model, which posits that health behavior change is determined by adequate information, sufficient personal and the acquisition of relevant behavioral skills. The information component will aim to improve participants' and their significant others' health literacy regarding hypertension and its management. The motivation component will focus on strengthening personal and social motivation for medication adherence and healthy self-care behaviors. The behavioral skills component will aim to equip participants with the practical skills necessary to maintain medication adherence and effectively perform recommended hypertension self-care behaviors.
Usual CareBehavioural
Participants in the control group will receive the usual hypertension care routinely provided at their respective public hospitals. No additional IMB Model-guided health literacy intervention will be provided during the study period.
| Study group | Role | What they receive |
|---|---|---|
| IMB Model-Guided Health Education Intervention arm | Experimental | Participants assigned to this arm will receive the Information-Motivation-Behavioral Skills (IMB) Model-guided health education intervention in addition to usual hypertension care. Receives: Behavioral: IMB Model-Guided Health Education Intervention |
| Usual Care Control | Active comparator | Participants in the control group will receive the usual hypertension care routinely provided at their respective public hospitals. No additional IMB Model-guided health literacy intervention will be provided during the study period. Receives: Behavioral: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number and proportion of participants adherent to antihypertensive medication, assessed using the four-item Morisky-Green-Levine Medication Adherence Scale
Medication adherence will be assessed using the four-item Morisky-Green-Levine Medication Adherence Scale. Each "Yes" response indicating non-adherent behavior will be scored 1, and each "No" response will be scored 0, yielding a total score ranging from 0 to 4. Participants scoring 0-1 will be classified as adherent, whereas those scoring 2-4 will be classified as non-adherent. The number and proportion of participants classified as adherent will be reported separately for the intervention and usual-care control groups.
Measured: Baseline and 4 months after the start of the intervention.
Secondary outcomes (1)
Number and Proportion of participants achieving blood pressure control based on systolic and diastolic blood pressure measurements
Blood pressure will be measured using a validated automated digital sphygmomanometer. Participants will sit quietly for at least 5 minutes before measurement, with their back supported, feet flat on the floor, and arm supported at heart level. Measurements will be taken on the right arm using an appropriately sized cuff. Three readings will be obtained at 1-2-minute intervals, and the average of the last two readings will be used for analysis. Participants will be instructed to avoid caffeine, smoking, and physical activity for at least 30 minutes before measurement. Blood pressure control will be defined as systolic blood pressure below 140 mmHg and diastolic blood pressure below 90 mmHg. The number and proportion of participants achieving blood pressure control will be reported separately for the intervention and usual-care control groups.
Measured: Baseline and 4 months after the start of the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2026
- Study start25 Jun 2026
- Primary completion25 Mar 2027 (estimated)
- Study completion25 May 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 230 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Bahir Dar University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Wallelign Alemnew Getnet, Bahir Dar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07894068
- Sponsor's protocol ID
- BDU-HTN-IMB-RCT-2026-003
- Status last verified
- Sep 2026
- First submitted
- 30 Sep 2026
- Last updated
- 26 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992 May;111(3):455-74. doi: 10.1037/0033-2909.111.3.455.
PubMed 1594721Guideline for the pharmacological treatment of hypertension in adults [Internet]. Geneva: World Health Organization; 2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK573631/
PubMed 34495610Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007.
PubMed 3945130
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Information-Motivation-Behavioral Skills -Based Intervention on Medication Adherence and Blood Pressure Control in North Ethiopia: A Cluster Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07894068
- Acronym / sponsor ID
- BDU-HTN-IMB-RCT-2026-003
- Conditions
- Hypertension
- Keywords
- Antihypertensive medication, Ethiopia, Hypertension self-management, IMB model
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 230 participants (estimated)
- Lead sponsor
- Bahir Dar UniversityUniversity, hospital or other
- Study start
- 25 Jun 2026 (actual)
- Primary completion
- 25 Mar 2027 (estimated)
- Study completion
- 25 May 2027 (estimated)
- First posted
- 26 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will evaluate the effectiveness of an Information-Motivation-Behavioral Skills (IMB) Model-guided health literacy intervention among adults with hypertension who are non-adherent to prescribed antihypertensive medication. The study will use a cluster randomized controlled trial design in eight public hospitals in North Ethiopia. Four hospitals will be allocated to the intervention group and four to the usual-care control group.
The intervention will address information, motivation, and behavioral skills related to medication adherence and hypertension self-management. Participants in the intervention group will receive the IMB Model-guided health literacy intervention in addition to usual care, while participants in the control group will receive usual care.
The primary outcome is medication adherence. Blood pressure control and other specified hypertension self-management outcomes will be assessed as secondary outcomes. In addition, a qualitative component will explore the perceptions, experiences, and contextual barriers of medication non-adherent hypertensive patients regarding the information, motivation, and behavioral skills that influence their medication adherence and hypertension self-care behaviors.
The study will test the hypothesis that the IMB Model-guided health literacy intervention will improve medication adherence compared with usual care. The qualitative component will provide contextual information to help explain participants' experiences and the factors influencing medication-taking behavior and intervention implementation.
Detailed description
This study is a mixed-methods study incorporating a cluster randomized controlled trial and a qualitative component. The quantitative component will evaluate the effectiveness of an Information-Motivation-Behavioral Skills (IMB) Model-guided health literacy intervention on medication adherence among non-adherent adults with hypertension.
The quantitative component will be conducted in eight public hospitals in North Ethiopia. Four hospitals will be allocated to the intervention group and four hospitals to the usual-care control group. Eligible adults with hypertension who meet the study criteria for medication non-adherence will be enrolled and followed according to the study protocol.
The intervention is guided by the Information-Motivation-Behavioral Skills Model. The information component will provide understandable and culturally appropriate information about hypertension, antihypertensive medications, medication adherence, and hypertension self-management. The motivation component will address personal and social factors influencing medication-taking behavior and provide appropriate motivational support. The behavioral skills component will focus on practical skills for establishing medication-taking routines, using reminders, addressing barriers to adherence, managing medication-related difficulties, problem-solving, and developing appropriate hypertension self-management strategies.
Participants in intervention hospitals will receive the IMB Model-guided health literacy intervention in addition to usual care. Participants in control hospitals will receive usual care provided by the participating health facilities. The intervention will be delivered according to the study protocol and standardized intervention materials, with appropriate procedures for monitoring intervention fidelity.
The primary quantitative outcome is medication adherence. Medication adherence will be assessed using the instrument and outcome definition specified in the approved study protocol. Blood pressure control will be assessed as a secondary outcome using standardized blood pressure measurement procedures. Other secondary outcomes will include the additional outcomes specified in the study protocol.
The qualitative component will explore the perceptions, experiences, and contextual barriers of medication non-adherent hypertensive patients regarding the information, motivation, and behavioral skills that influence medication adherence and hypertension self-care behaviors. The qualitative component will examine participants' understanding and experiences related to hypertension and antihypertensive medications, their sources of information, personal and social motivation for medication-taking, behavioral skills related to medication adherence and hypertension self-management, and contextual barriers that may influence these factors. It will also explore participants' experiences and perspectives regarding the challenges they face in maintaining medication adherence and hypertension self-care behaviors.
Qualitative data will be collected from purposively selected medication non-adherent hypertensive patients according to the qualitative component of the study protocol. The interviews will provide an in-depth understanding of the factors influencing medication-taking and hypertension self-care behaviors from the participants' perspectives. Qualitative data will be analyzed using an appropriate analysis approach, with findings organized around the information, motivation, behavioral skills, and contextual factors identified in the qualitative objective.
Data collection for both components will follow standardized procedures. Quantitative data will be collected by trained data collectors, and appropriate measures will be taken to maintain data quality and participant confidentiality. Qualitative interviews will be conducted by appropriately trained researchers, documented, transcribed, and analyzed according to the study protocol. Findings from the qualitative component will be considered alongside the quantitative findings to provide contextual understanding of medication adherence and hypertension self-care behaviors among medication non-adherent hypertensive patients.
The primary quantitative hypothesis is that participants receiving the IMB Model-guided health literacy intervention will demonstrate improved medication adherence compared with participants receiving usual care. The qualitative component will complement the quantitative findings by providing contextual information about participants' perceptions, experiences, and barriers related to information, motivation, and behavioral skills that influence medication adherence and hypertension self-care behaviors.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| IMB Model-Guided Health Education Intervention arm | Experimental | Behavioral: IMB Model-Guided Health Education InterventionParticipants assigned to this arm will receive the Information-Motivation-Behavioral Skills (IMB) Model-guided health education intervention in addition to usual hypertension care. |
| Usual Care Control | Active comparator | Behavioral: Usual CareParticipants in the control group will receive the usual hypertension care routinely provided at their respective public hospitals. No additional IMB Model-guided health literacy intervention will be provided during the study period. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adults aged 18 years and above.
- Documented diagnosis of hypertension (BP ≥140/90)
- ≥6 months on antihypertensive medication (this duration ensures stabilization of treatment regimens and allows reliable assessment of persistent medication adherence behavior and blood pressure outcomes).
- Identified as having poor medication adherence
Key exclusion criteria (1 listed)
- 1. Severe comorbidities that limit life expectancy or participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| IMB Model-Guided Health Education InterventionParticipants allocated to the intervention arm will receive a structured, face-to-face health literacy intervention in addition to usual hypertension care. The intervention will be guided by the IMB model, which posits that health behavior change is determined by adequate information, sufficient personal and the acquisition of relevant behavioral skills. The information component will aim to improve participants' and their significant others' health literacy regarding hypertension and its management. The motivation component will focus on strengthening personal and social motivation for medication adherence and healthy self-care behaviors. The behavioral skills component will aim to equip participants with the practical skills necessary to maintain medication adherence and effectively perform recommended hypertension self-care behaviors. | Behavioural | IMB Model-Guided Health Education Intervention arm |
| Usual CareParticipants in the control group will receive the usual hypertension care routinely provided at their respective public hospitals. No additional IMB Model-guided health literacy intervention will be provided during the study period. | Behavioural | Usual Care Control |
Primary outcome
Number and proportion of participants adherent to antihypertensive medication, assessed using the four-item Morisky-Green-Levine Medication Adherence Scale
Time frame: Baseline and 4 months after the start of the intervention.
Medication adherence will be assessed using the four-item Morisky-Green-Levine Medication Adherence Scale. Each "Yes" response indicating non-adherent behavior will be scored 1, and each "No" response will be scored 0, yielding a total score ranging from 0 to 4. Participants scoring 0-1 will be classified as adherent, whereas those scoring 2-4 will be classified as non-adherent. The number and proportion of participants classified as adherent will be reported separately for the intervention and usual-care control groups.
1 secondary outcome
Number and Proportion of participants achieving blood pressure control based on systolic and diastolic blood pressure measurements
Time frame: Baseline and 4 months after the start of the intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2026.
- Background: PubMed 1594721Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992 May;111(3):455-74. doi: 10.1037/0033-2909.111.3.455.
- Background: PubMed 34495610Guideline for the pharmacological treatment of hypertension in adults [Internet]. Geneva: World Health Organization; 2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK573631/
- Background: PubMed 3945130Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007.
- Individual participant dataSharing planned: No
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
8 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing IMB Model-Guided Health Education Intervention in people with Hypertension, run by Bahir Dar University at 8 sites in Ethiopia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in Ethiopia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Wallelign Alemnew Getnet, Master (+251982221932, wallelignaleminew@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number and proportion of participants adherent to antihypertensive medication, assessed using the four-item Morisky-Green-Levine Medication Adherence Scale (time frame: Baseline and 4 months after the start of the intervention.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07894068, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.